Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume 19, Issue 3, Pages 375-383Publisher
SPRINGER
DOI: 10.1007/s12253-012-9589-6
Keywords
Childhood cancer; Survivors; Endothelial dysfunction; Stiffness
Funding
- Health Science Council of the Ministry of Education Republic of Hungary (ETT) [396/2006, 01-478/2009]
- For the leukemic children foundations
- TAMOP 4.2.1./B-09/1/KONV-2010-0007 project
- European Union
- European Social Fund
Ask authors/readers for more resources
Vascular and endothelial functions were investigated in long term survivors of childhood cancer exposed to anthracycline treatment. We enrolled 96 long-term survivors (57 males and 39 females, mean age 14.9 +/- 5.3 year) of different childhood cancers and 72 age-, sex-, bodyweight- and blood pressure matched controls (39 males and 33 females, mean age 13.7 +/- 4.9 year). Aortic stiffness was characterized by echocardiography. Brachial artery endothelial function was assessed by flow-mediated dilatation (FMD%) and nitrate-mediated dilatation (NTG%). Results were compared between three subgroups: anthracycline treated, only chemotherapy treated and control subgroups. The cumulative anthracycline dose was less than 350 mg/m(2). The healthy control subgroup had a significantly greater FMD response (13.13 +/- 2.40 %), and lower stiffness index (2.08 +/- 0.6) than both the anthracycline (7.12 +/- 6.28 % and 6.45 +/- 3.25, respectively) and only chemotherapy treated (10.17 +/- 4.23 % and 4.12 +/- 2.32, respectively) subgroups. In the anthracycline treated subgroup a significantly (p < 0.01) lower FMD% response, and higher stiffness index were detected than in the only chemotherapy treated subgroup. Higher triglyceride level, higher cumulative anthracycline dose and lower age at the start of treatment were found to be associated independently with impairment of FMD% response and aortic stiffness. We found a significant negative correlation between FMD and aortic stiffness (p < 0.001) and a positive correlation between FMD and distensibility (p < 0.0001) Childhood cancer long term survivors exposed to anthracycline treatment exhibit a marked preclinical vasculopathy, characterized by endothelial dysfunction and increased arterial stiffness, contributing to a deteriorated cardiovascular function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available